Carregando...

Development of New Therapies for Severe Asthma

Persistent asthma has long been treated with inhaled corticosteroids (CSs), as the mainstay of therapy. However, their efficacy in patients with more severe disease is limited, which led to the incorporation of poor response to ICSs (and thereby use of high doses of ICS) into recent definitions of s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Allergy Asthma Immunol Res
Principais autores: Fajt, Merritt L., Wenzel, Sally E.
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102833/
https://ncbi.nlm.nih.gov/pubmed/27826957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2017.9.1.3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!